Jump to page content

Release of the National Strategy for Gene- and Cell-Based Therapies

Join us at the Futurium for the handover of the joint strategy paper with contributions from stakeholders and fields of action.


The Federal Ministry of Education and Research (BMBF) has commissioned the Berlin Institute of Health at Charité (BIH) to bring together relevant stakeholders from Germany to develop a national strategy for gene and cell therapies. These stakeholders include actors from science, business, politics and society as well as authorities, foundations and patient organizations. On June 12, 2024 , the jointly developed strategy paper will be presented to the Federal Minister of Education and Research, Bettina Stark-Watzinger, at the Futurium event.

Further information on the National Strategy.


Moderated by: Christina Berndt, science journalist and author

1:00 pm:    Open Doors/Admission

2:00 pm:    Welcome
Christopher Baum, Chairman of the Board of Directors of the Berlin Institute of Health at Charité (BIH)

2:05 pm:    Greetings
Bettina Stark-Watzinger, Federal Minister of Education and Research

2:15 pm:    Introduction National Strategy GCT
Christopher Baum, Spokesperson of the National Strategy GCT as well as Chairman of the BIH Board of Directors

2:25 pm:    Discussion with the rapporteurs for health research of the current political coalition in the German Parliament
Maximilian Funke-Kaiser, MdB FDP  
Laura Kraft, MdB Bündnis 90/Die Grünen
Ruppert Stüwe, MdB SPD

2:40 pm:    Official Handover of the National Strategy GCT

2:50 pm:    Panel Discussion: What measures are needed to successfully implement the strategy?
Talk with the representatives of the eight fields of action

I) Philipp Beckhove, Scientific Director Leibniz Institute for Immunotherapy Regensburg, Interventional Immunology, University of Regensburg

II) Axel Schambach, Director Institute of Experimental Hematology, Center Internal Medicine, Hannover Medical School and President Deutsche Gesellschaft für Gentherapie e.V. (DG-GT e.V.)

III) Ulrike Protzer, Director Institute of Virology at the School of Medicine and Health, Technical University of Munich and Helmholtz Munich

IV) Isabelle Stöckert, VP, Head Regulatory Affairs EMEA, Bayer AG Pharmaceuticals, Wuppertal

V) Sven Stegemann, Administrative Management Leibniz JointLab “First in Translation" at DWI – Leibniz Institute for Interactive Materials e.V., Aachen

VI) Michael Hudecek, Professorship Cellular Immunotherapy, Medical Clinic and Outpatient Clinic II, University Hospital Würzburg and Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Head of Cellular Immunotherapy Branch, Würzburg

VII) Francis Ayuk, Deputy Director Department of Stem Cell Transplantation, Center for Oncology, University Medical Center Hamburg-Eppendorf, Hamburg and Board Member Deutsche Arbeitsgemeinschaft für Hämatopoetische Stammzelltransplantation und Zelltherapie (DAG-HSZT) e.V., München

VIII) Tobias Cantz, Head of the Translational Hepatology and Stem Cell Biology Working Group, Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology at Hannover Medical School

3:40 pm:    Farewell
Christopher Baum, Chairman of the BIH Board of Directors

3:45 pm:    Reception

Fields of Action

          WG I: Stakeholder Networking and Support

          WG II: Training and Development of Skills

          WG III: Technology Transfer

          WG IV: Standards, Norms and Regulatory Framework

          WG V: Increase of Quality and Capacities for GMP Production

          WG VI: Research and Development

          WG VII: Marketing Authorization and Use in Patient Care

          WG VIII: Interaction with Society


June 12, 2024
at 2:00 pm

Alexanderufer 2
D-10117 Berlin
>> Parking facilities are limited. We recommend traveling by public transport.

Thank you for the great interest in the event.
Unfortunately, registration had to be closed due to limited space.
We are happy to add you to the waiting list. Please contact: gct-event@bih-charite.de

If you are a member of the press and would like to attend the event, please contact: pressestelle-bih@bih-charite.de


Dr. Elke Luger


National Network Office Gene and Cell Therapies

Contact information
Phone:+49 30 450 543 342